Eva Fortea Verdejo
Stock Analyst at Wells Fargo
(0.26)
# 3,669
Out of 4,667 analysts
3
Total ratings
33.33%
Success rate
-16.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eva Fortea Verdejo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Initiates: Overweight | $29 | $14.51 | +99.86% | 1 | Oct 8, 2024 | |
| ITOS iTeos Therapeutics | Initiates: Overweight | $31 | $7.90 | +292.41% | 1 | Aug 13, 2024 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Overweight | $34 | $20.82 | +63.30% | 1 | May 3, 2024 |
Arcus Biosciences
Oct 8, 2024
Initiates: Overweight
Price Target: $29
Current: $14.51
Upside: +99.86%
iTeos Therapeutics
Aug 13, 2024
Initiates: Overweight
Price Target: $31
Current: $7.90
Upside: +292.41%
Kiniksa Pharmaceuticals International,
May 3, 2024
Initiates: Overweight
Price Target: $34
Current: $20.82
Upside: +63.30%